The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.20
Bid: 33.00
Ask: 33.40
Change: 0.10 (0.30%)
Spread: 0.40 (1.212%)
Open: 33.10
High: 33.20
Low: 33.10
Prev. Close: 33.10
MERC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

12 Jul 2021 07:00

RNS Number : 8382E
Mercia Asset Management PLC
12 July 2021
 

RNS 12 July 2021

Mercia Asset Management PLC

("Mercia", the "Group" or the "Company")

Grant of Options

New Performance Share Plan ("PSP")

Mercia Asset Management PLC (AIM: MERC), the proactive, regionally focused specialist asset manager with c.£940million of assets under management, announces that, as noted in our recent full year preliminary results, Mercia wishes to incentivise its senior executives, aligning them with the future performance of the business and shareholders' interests. Mercia has therefore put in place a new performance share plan ("PSP") for the four senior executives. We believe this will both incentivise those senior executives and act as a powerful retention tool.

Pursuant to the PSP 8,800,000 nil cost options (the "PSP Options") over Ordinary Shares have been awarded to the Executive Directors and one further person discharging managerial responsibilities ("PDMR"). The options awarded under the new PSP sit within the existing 2014 Company Share Option Plan ("2014 CSOP Plan").

These PSP Options will, subject to the satisfaction of the performance condition, vest on the third anniversary of the date of grant of the options (the "Vesting Date") and be subject to a subsequent two-year holding period. The number of PSP Options which will vest on the Vesting Date will depend on the Company's total shareholder return ("TSR") over a performance period of three financial years, starting on the 1 April 2021. The number of PSP Options vesting will be calculated as follows: 50% of the PSP Options will vest based on the achievement of 10.0% TSR over the three-year performance period. Vesting will then increase on a straight-line basis to full vesting for the achievement of 20.0% TSR. TSR will be measured using the average share price for the 3 days prior to 31 March 2024. The PSP Options granted to the three Executive Directors and one PDMR are in line with the Group's remuneration policy and are subject to typical malus and clawback provisions.

Separately, pursuant to the 2014 CSOP Plan options over 2,220,000 Ordinary Shares ("CSOP Options") have been awarded to certain employees of the Company, including one PDMR, at an exercise price of 38.50p per Ordinary Share (being the closing mid-market price of an Ordinary Share on 9 July 2021). These CSOP Options will, subject to the satisfaction of the performance condition, vest in three equal tranches on the third, fourth and fifth anniversaries of the date of grant of the CSOP Options. The performance condition shall be satisfied if the total shareholder return (being the increase in the price of an Ordinary Share from a 38.50p base value added to dividend yield) from the date of grant to the third anniversary of the date of grant is not less than 8.0% (compound) per annum, using an average share price for the three days prior to the third anniversary of the date of grant.

Following the grant of these PSP Options and the CSOP Options above, the Company has a total of 31,804,140 unvested options in issue pursuant to the 2014 CSOP Plan, equating to 7.23% of the existing issued share capital of the Company.

Following the grant of these PSP Options and CSOP Options, the PDMRs listed below hold the following options and Ordinary Shares:

 

 

 

PDMR

Role

Grant of PSP or CSOP Options under 2014 CSOP Plan

Total number of options over Ordinary Shares

Interest in existing issued Ordinary Shares

Mark Payton

Chief Executive Officer

2,596,430

5,822,932

7,008,811

Martin Glanfield

Chief Financial Officer

2,113,652

4,936,697

1,427,417

Julian Viggars

Chief Investment Officer

2,113,652

5,736,697

846,385

Peter Dines

PDMR - Chief Operating Officer

1,976,266

4,845,813

419,389

Ross Gardner

PDMR - Group Financial Controller

200,000

200,000

Nil

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities:

1

Details of the persons discharging managerial responsibilities/person closely associated

a)

Name

(i) Mark Payton, Chief Executive Officer

(ii) Martin Glanfield, Chief Financial Officer

(iii) Julian Viggars, Chief Investment Officer

(iv) Peter Dines, Chief Operating Officer

(v) Ross Gardner, Group Financial Controller

2

Reason for the notification

a)

Position/status

Executive Directors and PDMRs of the Company

b)

Initial Notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mercia Asset Management PLC

b)

Legal Entity Identifier

213800A1Q4CF57NECG66

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Options over Ordinary Shares of £0.00001 each

 

ISIN - GB00BSL71W47

b)

Nature of transaction

Grant of options

c)

Currency

GBP

d)

Price(s) and volume(s)

Exercise Price

Options over Ordinary Shares

£0.00001

(i) 2,596,430

£0.00001

(ii) 2,113,652

£0.00001

(iii) 2,113,652

£0.00001

(iv) 1,976,266

£0.3850

(iv) 200,000

e)

Aggregate information

- Aggregate volume

- Price

- Aggregate total

N/A - single transactions

f)

Date of the transaction

9 July 2021

g)

Place of the transaction

Outside a trading venue

 

-ENDS-

Enquiries

Mercia Asset Management PLC

Mark Payton, Chief Executive Officer

Martin Glanfield, Chief Financial Officer

www.mercia.co.uk

 

+44 (0)330 223 1430

Canaccord Genuity Limited (NOMAD and Joint Broker)

Simon Bridges, Emma Gabriel

 

+44 (0)20 7523 8000

N+1 Singer (Joint Broker)

Harry Gooden, James Moat

 

+44 (0)20 7496 3000

FYI Consulting

Tom Blackwell, Louisa Feltes, Shiv Talwar

mercia@fticonsulting.com

+44 (0)20 3727 1051

 

About Mercia Asset Management PLC

Mercia is a proactive, specialist asset manager focused on supporting regional SMEs to achieve their growth aspirations. Mercia provides capital across its four asset classes of balance sheet, venture, private equity and debt capital: the Group's 'Complete Connected Capital'. The Group initially nurtures businesses via its third-party funds under management, then over time Mercia can provide further funding to the most promising companies, by deploying direct investment follow-on capital from its own balance sheet.

The Group has a strong UK footprint through its regional offices, 19 university partnerships and extensive personal networks, providing it with access to high-quality deal flow. Mercia currently has c.£940million of assets under management and, since its IPO in December 2014, has invested c.£111million gross into its direct investment portfolio.

Mercia Asset Management PLC is quoted on AIM with the EPIC "MERC".

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBCGDRRUBDGBB
Date   Source Headline
7th Aug 20187:00 amRNSOG wins significant multi-million pound contract
27th Jul 20189:30 amRNSPublication of Annual Report
17th Jul 20183:14 pmRNSPDMR / Director Dealings
2nd Jul 20187:00 amRNSPreliminary Results
20th Jun 20187:00 amRNSVirtTrade secures partnership with Formula 1
12th Jun 20187:00 amRNSBoard Appointment
21st May 20187:00 amRNSNotice of Preliminary Results
17th Apr 20187:00 amRNSBoard Change
26th Mar 20187:00 amRNSDeferred Consideration and Board Change
22nd Mar 20187:00 amRNSNew Direct Investment in Voxpopme
2nd Mar 20187:00 amRNSSale of Science Warehouse Limited
1st Feb 20187:00 amRNSMercia Annual Gala Dinner
22nd Dec 20177:00 amRNSBoard Appointment
18th Dec 20177:00 amRNSAmendment to Share Options
13th Dec 20177:00 amRNS£5.0million syndicated investment into Intechnica
11th Dec 20177:00 amRNS£3.8million syndicated investment into Medherant
6th Dec 20177:00 amRNSHalf Year Results
24th Nov 20177:00 amRNSImpression Technologies secures grant funding
17th Nov 20177:00 amRNSNew Direct Investment in £5.0m syndicated round
14th Nov 20177:00 amRNSLife Sciences & Biosciences sector update
1st Nov 20177:00 amRNSNew Partnership with the University of Edinburgh
31st Oct 20177:00 amRNSNotice of Results
25th Oct 20177:00 amRNSAppointment of Joint Broker
5th Oct 20177:00 amRNSFurther significant fund realisation achieved
3rd Oct 20177:00 amRNSWebsite launch
20th Sep 20177:00 amRNS£3.1million syndicated investment
18th Sep 201711:05 amRNSResult of AGM
18th Sep 20177:00 amRNSAGM statement
21st Aug 20177:00 amRNS£2.0m investment into Oxford Genetics
2nd Aug 20177:00 amRNSBoard Change
25th Jul 20177:00 amRNSGrant Options & PDMR Dealings
21st Jul 20177:00 amRNSPublication of Annual Report
13th Jul 20177:00 amRNSMercia invests additional £2.0million into nDreams
3rd Jul 20177:00 amRNSPreliminary results
21st Jun 20177:00 amRNSInvestment into Impression Tech & Sector Update
6th Jun 20177:00 amRNSFurther investment into Oxford Genetics
3rd May 20177:00 amRNSNotice of Preliminary Results
22nd Feb 20177:00 amRNSTwo major contracts for Northern Powerhouse Funds
17th Feb 201712:00 pmRNSNotification of Major Interest in Shares
16th Feb 201710:43 amRNSResult of General Meeting & Completion of Placing
31st Jan 20172:40 pmRNSPlacing of new Ordinary Shares to raise c.£40.0m
26th Jan 20177:00 amRNSNotice of Mercia Annual Gala Dinner
18th Jan 20177:00 amRNSNew Direct Investment in Faradion Limited
16th Dec 20167:00 amRNSSale of Allinea Software Limited to ARM
16th Nov 20167:00 amRNS£1m invested in nDreams as part of £2m syndication
10th Nov 20167:00 amRNSHalf Year Results
28th Oct 20167:00 amRNSNotice of Results
27th Oct 20167:00 amRNSInvestment in Oxford Genetics Limited
19th Oct 20167:00 amRNSWarwick Audio Technologies strengthens Board
11th Oct 20167:00 amRNSDigital & Digital Entertainment Portfolio Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.